127 related articles for article (PubMed ID: 17613775)
1. Effectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemia.
Benson DM; Smith MK
Leuk Lymphoma; 2007 Jul; 48(7):1423-5. PubMed ID: 17613775
[No Abstract] [Full Text] [Related]
2. Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for the treatment of secondary plasma cell leukemia.
Jimenez-Zepeda VH; Reece DE; Trudel S; Chen C; Tiedemann R; Kukreti V
Leuk Lymphoma; 2015 Jan; 56(1):232-5. PubMed ID: 24884320
[No Abstract] [Full Text] [Related]
3. Salvage therapy with lenalidomide and dexamethasone in relapsed primary plasma cell leukemia.
Musto P; Pietrantuono G; Guariglia R; Villani O; Martorelli MC; D'Auria F; Zonno A; Lerose R
Leuk Res; 2008 Oct; 32(10):1637-8. PubMed ID: 18433866
[No Abstract] [Full Text] [Related]
4. Thalidomide-induced pneumonitis in a patient with plasma cell leukemia: No recurrence with subsequent lenalidomide therapy.
Pretz J; Medeiros BC
Am J Hematol; 2009 Oct; 84(10):698-9. PubMed ID: 19691102
[No Abstract] [Full Text] [Related]
5. Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia.
Musto P; Simeon V; Martorelli MC; Petrucci MT; Cascavilla N; Di Raimondo F; Caravita T; Morabito F; Offidani M; Olivieri A; Benevolo G; Mina R; Guariglia R; D'Arena G; Mansueto G; Filardi N; Nobile F; Levi A; Falcone A; Cavalli M; Pietrantuono G; Villani O; Bringhen S; Omedè P; Lerose R; Agnelli L; Todoerti K; Neri A; Boccadoro M; Palumbo A
Leukemia; 2014 Jan; 28(1):222-5. PubMed ID: 23958922
[No Abstract] [Full Text] [Related]
6. Lenalidomide can induce graft versus leukemia effect in primary plasma cell leukemia: a case report.
Olivieri A; Attolico I; Cimminiello M; Discepoli G; Cifarelli RA
Leuk Res; 2009 Nov; 33(11):e191-3. PubMed ID: 19476997
[No Abstract] [Full Text] [Related]
7. Thalidomide does not modify the prognosis of plasma cell leukemia patients: experience of a single center.
Petrucci MT; Martini V; Levi A; Gallucci C; Palumbo G; Del Bianco P; Torromeo C; Foà R
Leuk Lymphoma; 2007 Jan; 48(1):180-2. PubMed ID: 17325863
[No Abstract] [Full Text] [Related]
8. Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia.
Gozzetti A; Musto P; Defina M; D'Auria F; Papini G; Statuto T; D'Arena G; Bocchia M
Br J Haematol; 2012 May; 157(4):497-8. PubMed ID: 22296516
[No Abstract] [Full Text] [Related]
9. [Plasma cell leukaemia].
Rodriguez C; Pont JC; Gouin-Thibault I; Andrieu AG; Molina T; Le Tourneau A; Le Garff-Tavernier M; Siguret V; Chaibi P
Ann Biol Clin (Paris); 2005; 63(5):535-9. PubMed ID: 16230292
[TBL] [Abstract][Full Text] [Related]
10. Resident rounds part III: plasma cell leukemia with initial cutaneous presentation.
Fabbro SK; Kaffenberger BH
J Drugs Dermatol; 2014 Aug; 13(8):994-5. PubMed ID: 25271340
[No Abstract] [Full Text] [Related]
11. Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?
Mian M; Tinelli M; DE March E; Turri G; Meneghini V; Pescosta N; Berno T; Marabese A; Mondello P; Patriarca F; Pizzolo G; Semenzato G; Cortelazzo S; Zambello R
Anticancer Res; 2016 Mar; 36(3):1059-65. PubMed ID: 26976998
[TBL] [Abstract][Full Text] [Related]
12. A phase I study of oral CC-5013 (lenalidomide, Revlimid), a thalidomide derivative, in patients with refractory metastatic cancer.
Tohnya TM; Ng SS; Dahut WL; Wright JJ; Arlen PM; Gulley JL; Parker C; Zeldis J; Figg WD
Clin Prostate Cancer; 2004 Mar; 2(4):241-3. PubMed ID: 15072608
[No Abstract] [Full Text] [Related]
13. Use of lenalidomide in treating refractory prurigo nodularis.
Liu H; Gaspari AA; Schleichert R
J Drugs Dermatol; 2013 Mar; 12(3):360-1. PubMed ID: 23545923
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide administration for the treatment of resistant plasma cell leukemia.
Tsiara S; Chaidos A; Kapsali H; Tzouvara E; Bourantas KL
Acta Haematol; 2003; 109(3):153-5. PubMed ID: 12747371
[No Abstract] [Full Text] [Related]
15. Effective treatment of primary plasma cell leukemia with thalidomide and dexamethasone - a case report.
Wöhrer S; Ackermann J; Baldia C; Seidl S; Raderer M; Simonitsch I; Drach J
Hematol J; 2004; 5(4):361-3. PubMed ID: 15297854
[TBL] [Abstract][Full Text] [Related]
16. Response to pomalidomide plus fixed low-dose dexamethasone in a case of secondary plasma cell leukaemia.
Mele G; Coppi MR; Guaragna G; Spina A; Melpignano A
Leuk Res; 2016 Jan; 40():30-2. PubMed ID: 26626205
[TBL] [Abstract][Full Text] [Related]
17. Plasma cell leukemia mimicking hairy cell leukemia.
Hanbali A; Alrajeh A; Rasheed W
Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):91-2. PubMed ID: 26013472
[No Abstract] [Full Text] [Related]
18. Managing plasma cell leukemia.
Gertz MA
Leuk Lymphoma; 2007 Jan; 48(1):5-6. PubMed ID: 17325841
[No Abstract] [Full Text] [Related]
19. Plasma cell leukemia: concepts and management.
Liedtke M; Medeiros BC
Expert Rev Hematol; 2010 Oct; 3(5):543-9. PubMed ID: 21083471
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment for plasma cell leukemia].
Miwa A
Nihon Rinsho; 2012 Apr; 70 Suppl 2():628-41. PubMed ID: 23134023
[No Abstract] [Full Text] [Related]
[Next] [New Search]
